Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For UCBIO
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 38.31 0.08 0.06
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -75.86 41.21 -170.70
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.14 27.58 27.27
Cash 0.43 36.40 36.24
Capex -2.82 -0.11 -0.11
Free Cash Flow 849.42 0.67 0.07
Revenue 18.91 3.14 2.64
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -28.77 0.71 1.00
Operating Margin 102931.00 0.25 < 0.005
ROA 343.41 < 0.005 < 0.005
ROE 339.31 0.02 < 0.005
ROIC 74484.55 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of UCBIO is permitted for members.
5 Growth
The "Growth Entry" for the Focus of UCBIO is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of UCBIO is permitted for members.